Plasma treatment for cervical HPV infections
Treatments studied
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study tests a new non-invasive plasma treatment for cervical infections caused by high- and low-risk HPV types. It may help clear the virus and prevent related health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have tested positive for HPV (via a swab test)
- Your cervix has a clearly visible area for treatment or monitoring
- You are willing to sign a consent form to join the study
- You do not have signs of invasive cancer or serious heart conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.
This study tests a new vaginal medication (Dysplasix) to treat mild cervical cell changes caused by high-risk HPV. The goal is to see if this treatment can help your body clear the virus and prevent these changes from getting worse.
This trial tests a new vaccine (pBI-11) given with a device that uses mild electric pulses to help the vaccine enter cells. It is for people who have HPV16 or 18 but no high-grade cervical changes.
This trial aims to develop a vaccine that trains your immune system to fight HPV, the virus that causes cervical cancer. By studying your blood, researchers hope to find better ways to prevent the cancer from coming back.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This trial compares two ways of managing CIN 2, a moderate precancerous change on the cervix. One option is a new procedure that uses argon plasma (a type of energized gas) to treat the area; the other is careful monitoring without immediate treatment, to see if one works better at clearing the abnormal cells.
Hear when a new HPV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.